Fri, June 28, 2024

Luke Sergott Maintained (TXG) at Buy with Decreased Target to $24 on, Jun 28th, 2024

Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $36 to $24 on, Jun 28th, 2024.

Luke has made no other calls on TXG in the last 4 months.



There are 10 other peers that have a rating on TXG. Out of the 10 peers that are also analyzing TXG, 6 agree with Luke's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Doug Schenkel of "Wolfe Research" Downgraded from Buy to Hold on, Thursday, June 27th, 2024
  • Subbu Nambi of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, June 26th, 2024
  • Tycho Peterson of "Jefferies" Initiated at Hold and Held Target at $24 on, Monday, June 3rd, 2024
  • Dan Brennan of "TD Cowen" Downgraded from Strong Buy to Hold and Decreased Target to $32 on, Wednesday, May 1st, 2024
  • Dan Leonard of "UBS" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 1st, 2024
  • Derik De Bruin of "B of A Securities" Maintained at Hold with Decreased Target to $36 on, Wednesday, May 1st, 2024


These are the ratings of the 4 analyists that currently disagree with Luke


  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $26 on, Wednesday, May 1st, 2024
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $53 on, Wednesday, May 1st, 2024
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Monday, April 29th, 2024
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $55 on, Thursday, April 18th, 2024